Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W K Goodman

Showing results (21-30 of 92) with videos related to

Pageof 10
Sort By:
Seminars in Clinical Neuropsychiatry|October 19, 2001
Obsessive compulsive disorder: is there an association with childhood streptococcal infections and altered immune function?T K Murphy, J M Petitto, K K Voeller, et al.
The American Journal of Psychiatry|October 1, 1989
Pathophysiology of obsessive-compulsive disorderC J McDougle, W K Goodman, P L Delgado, et al.
The American Journal of Psychiatry|August 1, 1987
Neurobiological mechanisms of panic anxiety: biochemical and behavioral correlates of yohimbine-induced panic attacksD S Charney, S W Woods, W K Goodman, et al.
Archives of Psychiatric Nursing|October 1, 1991
Current treatment approaches to obsessive-compulsive disorderB K Boyarsky, L A Perone, N C Lee, et al.
Archives of General Psychiatry|January 1, 1988
Carbon dioxide-induced anxiety. Behavioral, physiologic, and biochemical effects of carbon dioxide in patients with panic disorders and healthy subjectsS W Woods, D S Charney, W K Goodman, et al.
Psychopharmacology|January 1, 1987
Serotonin function in anxiety. II. Effects of the serotonin agonist MCPP in panic disorder patients and healthy subjectsD S Charney, S W Woods, W K Goodman, et al.
Neuroreport|January 11, 2005
Disgust and the insula: fMRI responses to pictures of mutilation and contaminationP Wright, G He, N A Shapira, et al.
Psychoneuroendocrinology|March 31, 1999
Possible role of neuropeptides in obsessive compulsive disorderC J McDougle, L C Barr, W K Goodman, et al.
Biological Psychiatry|May 16, 2000
On defining Sydenham's chorea: where do we draw the line?T K Murphy, W K Goodman, E M Ayoub, et al.
The Psychiatric Clinics of North America|December 1, 1993
The psychopharmacology of obsessive compulsive disorder. Implications for treatment and pathogenesisC J McDougle, W K Goodman, J F Leckman, et al.
Pageof 10

Showing results (21-30 of 92) with videos related to

Sort By:
Pageof 10
Seminars in Clinical Neuropsychiatry|October 19, 2001
Obsessive compulsive disorder: is there an association with childhood streptococcal infections and altered immune function?T K Murphy, J M Petitto, K K Voeller, et al.
The American Journal of Psychiatry|October 1, 1989
Pathophysiology of obsessive-compulsive disorderC J McDougle, W K Goodman, P L Delgado, et al.
The American Journal of Psychiatry|August 1, 1987
Neurobiological mechanisms of panic anxiety: biochemical and behavioral correlates of yohimbine-induced panic attacksD S Charney, S W Woods, W K Goodman, et al.
Archives of Psychiatric Nursing|October 1, 1991
Current treatment approaches to obsessive-compulsive disorderB K Boyarsky, L A Perone, N C Lee, et al.
Archives of General Psychiatry|January 1, 1988
Carbon dioxide-induced anxiety. Behavioral, physiologic, and biochemical effects of carbon dioxide in patients with panic disorders and healthy subjectsS W Woods, D S Charney, W K Goodman, et al.
Psychopharmacology|January 1, 1987
Serotonin function in anxiety. II. Effects of the serotonin agonist MCPP in panic disorder patients and healthy subjectsD S Charney, S W Woods, W K Goodman, et al.
Neuroreport|January 11, 2005
Disgust and the insula: fMRI responses to pictures of mutilation and contaminationP Wright, G He, N A Shapira, et al.
Psychoneuroendocrinology|March 31, 1999
Possible role of neuropeptides in obsessive compulsive disorderC J McDougle, L C Barr, W K Goodman, et al.
Biological Psychiatry|May 16, 2000
On defining Sydenham's chorea: where do we draw the line?T K Murphy, W K Goodman, E M Ayoub, et al.
The Psychiatric Clinics of North America|December 1, 1993
The psychopharmacology of obsessive compulsive disorder. Implications for treatment and pathogenesisC J McDougle, W K Goodman, J F Leckman, et al.
Pageof 10